MediPharm Labs (TSE:LABS) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
MediPharm Labs is selling its Napanee facility to Kensana Health for $5.5 million, forming a strategic partnership to enhance their manufacturing capabilities and support future growth. This move aligns with MediPharm’s strategy to streamline operations and maximize stakeholder value, while Kensana aims to advance its phytopharmaceutical development. The deal is expected to close by January 1, 2025.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.
